Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
kangfuxin enteric-coated capsule
- Development stage
- Unknown
- Lead developer
- Jingxin Pharmaceutical
- Administration
- Oral
01
Overview
Kangfuxin enteric-coated capsule is a pharmaceutical preparation containing the extract of *Periplaneta americana* (American cockroach), developed by Zhejiang Jingxin Pharmaceutical. This therapeutic is specifically designed as an enteric-coated formulation to ensure the targeted release of active components in the intestines, making it suitable for treating inflammatory bowel diseases. The extract is a complex mixture rich in active peptides, amino acids, and polyols that promote mucosal healing, stimulate the growth of granulation tissue, and exert anti-inflammatory and immunomodulatory effects. It is currently in Phase III clinical development in China for the treatment of mild-to-moderate active ulcerative colitis, aiming to induce clinical remission and mucosal repair.
- Brand names
- Kangfuxin
- Other names
- Kangfuxin Changrong JiaonangPeriplaneta americana extract enteric-coated capsule
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))VEGFA (Vascular endothelial growth factor A)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on kangfuxin enteric-coated capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on kangfuxin enteric-coated capsule.